Medical News

RSS

Alnylam Pharmaceuticals and Roche team up to develop specific RNAi therapeutic products

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has advanced to the RNAi therapeutic collaboration stage of its landmark alliance with Roche formed in 2007.

4 Nov 2009

Shire receives FDA Priority Review for velaglucerase alfa NDA

Shire plc, the global specialty biopharmaceutical company, today announced that the United States Food and Drug Administration (FDA) has granted Priority Review for the New Drug Application (NDA) for velaglucerase alfa, the company's enzyme replacement therapy in development for the treatment of Type 1 Gaucher disease.

4 Nov 2009

AHDI and MTIA support healthcare reform package

As health information managers and professionals across the country celebrate the health information & technology industry this week, the Association for Health Care Documentation Integrity (AHDI) and the Medical Transcription Industry Association (MTIA) announced their support for a healthcare reform package that improves electronic health records (EHRs) as well as patient safety.

4 Nov 2009

Osiris Therapeutics reports financial results for the third quarter of 2009

Osiris Therapeutics, Inc., the leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular and orthopedic areas, announced today its financial results for the third quarter of 2009.

4 Nov 2009

New pediatric simulation center launched by Texas Children's Hospital

Texas Children's Hospital opened the doors of its brand new Simulation Center today, where healthcare teams will be trained in the management of rare, complex, and complicated patient care through a simulated clinical environment. The facility is the only center of its kind in Texas, and one of the largest among the twelve pediatric simulation centers in the United States.

4 Nov 2009

Celldex announces third quarter and nine-month period results; acquires a net loss of $7.2 million

Celldex Therapeutics, Inc. today reported financial results for the third quarter and nine-month period ended September 30, 2009. Celldex reported a net loss of $7.2 million, or $0.45 per share, for the third quarter of 2009 compared to a net loss of $7.7 million, or $0.49 per share, for the third quarter of 2008.

4 Nov 2009

Cornerstone Therapeutics announces financial results for the third quarter of 2009

Cornerstone Therapeutics Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today reported financial results for the three and nine months ended September 30, 2009.

4 Nov 2009

Third quarter 2009 financial results announced by Synta Pharmaceuticals

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported financial results for the quarter ended September 30, 2009.

4 Nov 2009

USPTO issues Notice of Allowance for Transcept Pharmaceuticals' Intermezzo

Transcept Pharmaceuticals, Inc. today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for claims under U.S. patent application no. 11/833,323, which covers the use of Intermezzo® (zolpidem tartrate sublingual tablet), the lead Transcept product candidate. Once issued, this patent will expire in February 2025.

4 Nov 2009

Third-quarter fiscal 2009 results announced by Vitamin Shoppe

Vitamin Shoppe, Inc., a leading specialty retailer and direct marketer of nutritional products, today announced results for its fiscal third quarter ended September 26, 2009.

4 Nov 2009

CPEX Pharmaceuticals announces third-quarter results; reports net loss of $872,000

CPEX Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2009. For the quarter CPEX reported revenues of $5.0 million and a net loss of $872,000.

4 Nov 2009

Henry Schein announces record financial results for third quarter 2009; reports net sales growth in local currencies

Henry Schein, Inc. (Nasdaq: HSIC), the largest provider of healthcare products and services to office-based practitioners, today reported record financial results for the quarter ended September 26, 2009.

4 Nov 2009

Cipher Pharmaceuticals announces financial results for the third quarter of 2009

Cipher Pharmaceuticals Inc. today announced its financial and operational results for the three and nine months ended September 30, 2009.

4 Nov 2009

CMS releases WellCare Health Plans from the previously disclosed sanctions

WellCare Health Plans, Inc. today announced that the Centers for Medicare & Medicaid Services (“CMS”) released the Company from the previously disclosed sanctions, except as noted below. The Company will resume marketing its Medicare Prescription Drug Plans and Medicare Advantage coordinated care plans over the coming days.

4 Nov 2009

Osteotech signs tissue supply agreement with CTS

Osteotech, Inc. (Nasdaq: OSTE), a leader in the emerging field of biologic products for regenerative healing, announced today that it entered into a multi-year tissue supply agreement with Community Tissue Services (CTS), with an initial term spanning 10 years.

4 Nov 2009

WellCare Health Plans announces financial results for the third quarter of 2009

WellCare Health Plans, Inc. today reported results for the third quarter and nine months ended September 30, 2009. As determined under generally accepted accounting principles (“GAAP”), the Company reported net income of $28.7 million, or $0.68 per diluted share, for the third quarter 2009, compared with a net loss of $18.2 million, or $0.44 per diluted share, for the third quarter 2008.

4 Nov 2009

Cosmeceutical industry records increased growth

The global market for cosmeceuticals (cosmetics offering health benefits) is growing nearly twice as fast as the overall cosmetics and toiletries market. However, in order to sustain such rapid growth, manufacturers and brand owners must fill a relentless demand for new ingredient concepts in a context of changing government regulations, market dynamics and cultural trends.

4 Nov 2009

Exelixis to present 13 abstracts of its development candidates at the 2009 AACR-NCI-EORTC Conference

Exelixis, Inc. announced today that thirteen abstracts related to the company’s development candidates have been accepted for presentation at the 2009 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, which is being held November 15-19 in Boston. Interim data from ongoing phase 1 clinical trials of XL147 and XL765 will be reported in four poster presentations.

4 Nov 2009

Aquilion Premium CT system installed by Huntington Hill Imaging Center

Today’s high-volume health care facilities require premium diagnostic imaging equipment that can image patients faster, with the best possible diagnostic accuracy. Huntington Hill Imaging Center has installed Toshiba America Medical Systems, Inc.’s Aquilion® Premium CT system, to enable them to meet the demands of their growing business.

4 Nov 2009

ResearchPoint celebrates 10th anniversary

ResearchPoint is celebrating 10 years of industry-leading service to the pharmaceutical, biotech and medical device industries.

4 Nov 2009

Medical News

Alnylam Pharmaceuticals and Roche team up to develop specific RNAi therapeutic products

Shire receives FDA Priority Review for velaglucerase alfa NDA

AHDI and MTIA support healthcare reform package

Osiris Therapeutics reports financial results for the third quarter of 2009

New pediatric simulation center launched by Texas Children's Hospital

Celldex announces third quarter and nine-month period results; acquires a net loss of $7.2 million

Cornerstone Therapeutics announces financial results for the third quarter of 2009

Third quarter 2009 financial results announced by Synta Pharmaceuticals

USPTO issues Notice of Allowance for Transcept Pharmaceuticals' Intermezzo

Third-quarter fiscal 2009 results announced by Vitamin Shoppe

CPEX Pharmaceuticals announces third-quarter results; reports net loss of $872,000

Henry Schein announces record financial results for third quarter 2009; reports net sales growth in local currencies

Cipher Pharmaceuticals announces financial results for the third quarter of 2009

CMS releases WellCare Health Plans from the previously disclosed sanctions

Osteotech signs tissue supply agreement with CTS

WellCare Health Plans announces financial results for the third quarter of 2009

Cosmeceutical industry records increased growth

Exelixis to present 13 abstracts of its development candidates at the 2009 AACR-NCI-EORTC Conference

Aquilion Premium CT system installed by Huntington Hill Imaging Center

ResearchPoint celebrates 10th anniversary

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News